Tufts: Biologics Makers Need More Adaptable Strategies

Generic Line
A A
Makers of biopharmaceuticals will need to become more modular and agile to adjust for trends in personalized medicine and oncology, according to the Tufts Center for the Study of Drug Development.

To View This Article:

Login

Subscribe To Generic Line